Artificial intelligence algorithm for neoplastic cell percentage estimation and its application to copy number variation in urinary tract cancer

키워드

참고문헌 (40)

1. Robertson AG, "Comprehensive molecular characterization of muscle-invasive bladder cancer", Cell, 174, pp.1033~ (2018)
2. Loriot Y, "Erdafitinib in locally advanced or metastatic urothelial carcinoma", N Engl J Med, 381, pp.338~348 (2019)
3. Sheng X, "Open-label, multicenter, phase II study of RC48-ADC, a HER2-targeting antibody-drug conjugate, in patients with locally advanced or metastatic urothelial carcinoma", Clin Cancer Res, 27, pp.43~51 (2021)
4. Patelli G, "The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer : a systematic review and future perspectives", Cancer Treat Rev, 104, pp.102351~ (2022)
5. Zare F, "An evaluation of copy number variation detection tools for cancer using whole exome sequencing data", BMC Bioinformatics, 18, pp.286~ (2017)
6. Smits AJ, "The estimation of tumor cell percentage for molecular testing by pathologists is not accurate", Mod Pathol, 27, pp.168~174 (2014)
7. Dufraing K, "Neoplastic cell percentage estimation in tissue samples for molecular oncology : recommendations from a modified Delphi study", Histopathology, 75, pp.312~319 (2019)
8. Haider S, "Systematic assessment of tumor purity and its clinical implications", JCO Precis Oncol, 4, pp.PO.20.00016~ (2020)
9. Yadav VK, "An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples", Brief Bioinform, 16, pp.232~241 (2015)
10. Baxi V, "Digital pathology and artificial intelligence in translational medicine and clinical practice", Mod Pathol, 35, pp.23~32 (2022)
11. Azimi V, "Breast cancer histopathology image analysis pipeline for tumor purity estimation", Proc IEEE Int Symp Biomed Imaging, 2017, pp.1137~1140 (2017)
12. Lin S, "Digital quantification of tumor cellularity as a novel prognostic feature of non-small cell lung carcinoma", Mod Pathol, 36, pp.100055~ (2023)
13. Amin MB, "Histological variants of urothelial carcinoma : diagnostic, therapeutic and prognostic implications", Mod Pathol, 22(Suppl 2), pp.S96~S118 (2009)
14. Ahn J, "Immune profiling of advanced thyroid cancers using fluorescent multiplex immunohistochemistry", Thyroid, 31, pp.61~67 (2021)
15. Bankhead P, "QuPath : open source software for digital pathology image analysis", Sci Rep, 7, pp.16878~ (2017)
16. Schmidt U, "Medical Image Computing and Computer Assisted Intervention - MICCAI 2018" (2018)
17. Paszke A, "Pytorch: an imperative style, highperformance deep learning library", Advances in Neural Information Processing Systems 32, NeurIPS 2019 (2019)
18. Krizhevsky A, "ImageNet classification with deep convolutional neural networks", Proceedings of the 25th International Conference on Neural Information Processing Systems, 1 (2012)
19. "Very deep convolutional networks for large-scale image recognition" (2014)[URL]
20. He K, "Deep residual learning for image recognition", 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) (2016)
21. "Wide residual networks" (2016)[URL]
22. Tan M, "EfficientNet: rethinking model scaling for convolutional neural networks", Proceedings of the 36th International Conference on Machine Learning (PMLR) (2019)
23. Tan M, "Efficientnetv2 : smaller models and faster training", Proceedings of the 38th International Conference on Machine Learning (PMLR) (2021)
24. Sandler M, "Mobilenetv2:inverted residuals and linear bottlenecks", Proceedings of the IEEE, 2018, ~
25. Howard A, "Searching for MobileNetV3", Proceedings of the IEEE, 2019, ~
26. Ma N, "Shufflenet v2 : practical guidelines for efficient CNN architecture design", Proceedings of the European Conference on Computer Vision (ECCV 2018) (2018)
27. "Adam: a method for stochastic optimization" (2014)[URL]
28. Shrout PE, "Intraclass correlations : uses in assessing rater reliability", Psychol Bull, 86, pp.420~428 (1979)
29. Robert ME, "High interobserver variability among pathologists using combined positive score to evaluate PDL1expression in gastric, gastroesophageal junction, and esophageal adenocarcinoma", Mod Pathol, 36, pp.100154~ (2023)
30. Cicchetti DV, "Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology", Psychol Assess, 6, pp.284~290 (1994)
31. Kim JE, "Mutation burden and I index for detection of microsatellite instability in colorectal cancer by targeted next-generation sequencing", J Mol Diagn, 21, pp.241~250 (2019)
32. Kim M, "Validation and clinical application of ONCOaccuPanel for targeted next-generation sequencing of solid tumors", Cancer Res Treat, 55, pp.429~441 (2023)
33. Oh JH, "BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy", J Pathol Transl Med, 57, pp.323~331 (2023)
34. Talevich E, "CNVkit : genome-wide copy number detection and visualization from targeted DNA sequencing", PLoS Comput Biol, 12, pp.e1004873~ (2016)
35. Tate JG, "COSMIC : the catalogue of somatic mutations In cancer", Nucleic Acids Res, 47, pp.D941~D947 (2019)
36. Zhao M, "Concordance of copy number loss and down-regulation of tumor suppressor genes : a pan-cancer study", BMC Genomics, 17(Suppl 7), pp.532~ (2016)
37. Suehnholz SP, "Quantifying the expanding landscape of clinical actionability for patients with cancer", Cancer Discov, 14, pp.49~65 (2024)
38. Homeyer A, "Recommendations on compiling test datasets for evaluating artificial intelligence solutions in pathology", Mod Pathol, 35, pp.1759~1769 (2022)
39. Lhermitte B, "Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment", Virchows Arch, 470, pp.21~27 (2017)
40. Sakamoto T, "A collaborative workflow between pathologists and deep learning for the evaluation of tumour cellularity in lung adenocarcinoma", Histopathology, 81, pp.758~769 (2022)

관련 논문AI추천